4//SEC Filing
APP Pharmaceuticals, Inc. 4
Accession 0001181431-08-053267
CIK 0001141399operating
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 7:33 PM ET
Size
5.8 KB
Accession
0001181431-08-053267
Insider Transaction Report
Form 4
Themba 2005 Trust II
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2008-09-10−34,899,338→ 0 total
Footnotes (1)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger, dated as of July 6, 2008, among Fresenius SE, Fresenenius Kabi Pharmaceuticals Holding, Inc. (formerly Frensenius Kabi Pharmaceuticals Holding LLC), Fresenius Kabi Pharmaceuticals, LLC ("Merger Sub") and APP Pharmaceuticals, Inc. ("APP"), whereby Merger Sub merged into APP with APP continuing as the surviving company and an indirect wholly owned subsidiary of Fresenius SE, in exchange for (x) an amount in cash equal to $23.00 plus (y) a contingent value right issued by Holdco.
Documents
Issuer
APP Pharmaceuticals, Inc.
CIK 0001141399
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001141399
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 7:33 PM ET
- Size
- 5.8 KB